Cabaletta Bio
Stock Forecast, Prediction & Price Target
Cabaletta Bio Financial Estimates
Cabaletta Bio Revenue Estimates
Cabaletta Bio EBITDA Estimates
Cabaletta Bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $6.25M Low: $6.25M High: $6.25M avg. 0% | Avg: $2.14M Low: $2.14M High: $2.14M avg. -65.71% | Avg: $105.82M Low: $105.82M High: $105.82M avg. 4838.51% | Avg: $364.07M Low: $364.07M High: $364.07M avg. 244.03% |
Net Income
% change YoY
| $-45.53M N/A | $-51.81M -13.79% | $-67.67M -30.61% | Avg: $-122.36M Low: $-117.92M High: $-40.53M avg. -80.81% | Avg: $-148.38M Low: $-106.86M High: $-63.05M avg. -21.26% | Avg: $-65.51M Low: $-65.51M High: $-65.51M avg. 55.85% | Avg: $-5.75M Low: $-5.75M High: $-5.75M avg. 91.21% |
EBITDA
% change YoY
| $-46.31M N/A | $-54.13M -16.89% | $-73.23M -35.27% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.77 N/A | -$1.77 0% | -$1.65 6.77% | Avg: -$2.22 Low: -$2.88 High: -$0.99 avg. -34.30% | Avg: -$2.27 Low: -$2.61 High: -$1.54 avg. -2.64% | Avg: -$1.6 Low: -$1.6 High: -$1.6 avg. 29.66% | Avg: -$0.14 Low: -$0.14 High: -$0.14 avg. 91.21% |
Operating Expenses
% change YoY
| $46.31M N/A | $54.13M 16.89% | $74.66M 37.90% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Cabaletta Bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 11.24% in 2025-2028.
We have gathered data from 9 analysts. Their low estimate is -117.92M, average is -122.36M and high is -40.53M.
What is Cabaletta Bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1254.20% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $6.25M, average is $6.25M and high is $6.25M.
What is Cabaletta Bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 20.98% in 2025-2028.
We have gathered data from 9 analysts. Their low earnings per share estimate is -$2.88, average is -$2.22 and high is $-0.99.
What is the best performing analyst?
In the last twelve months analysts have been covering Cabaletta Bio stock. The most successful analyst is Ben Burnett.